Oticon More vs RxEars Rxi

The Oticon More is a premium prescription behind-the-ear hearing aid that earns an A grade with a SoundScore of 4.6/5 in our lab testing, placing it in the top 23% of the 39 prescription hearing aids we've evaluated. Currently available at $4,598, this 2021 release has earned our Expert's Choice Award in both 2023 and 2024. In our testing, the Oticon More demonstrates strong speech clarity performance. Speech in quiet scores 4.0/5, which is 0.65 points above the category average—a meaningful advantage for everyday conversation. Speech in noise measures 2.7/5, which is 0.60 points above the category average, though the absolute score reflects the inherent challenge all hearing aids face in noisy environments. Own-voice comfort is solid at 3.1/5, sitting 0.40 points above average. The device does show one notable weakness: feedback handling scores 3.5/5, which is 1.22 points below the category average of 4.72/5. While this is still a solid score in absolute terms, competing devices in this price range generally perform better in this area. Music streaming is solid at 3.0/5, slightly above the category average. The Oticon More offers flexibility with both rechargeable and disposable battery options, plus streaming compatibility with both iPhone and Android devices including hands-free calling. For those considering alternatives, newer models like the Oticon Intent and Oticon Real score higher in our testing at similar price points. The Oticon More remains a capable choice for listeners who prioritize speech clarity and want a well-established platform with proven performance.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.